Nessler J, Tipold A
Front Vet Sci. 2024; 11:1465689.
PMID: 39474275
PMC: 11518845.
DOI: 10.3389/fvets.2024.1465689.
Seo S, Hattori M, Yoshida T
Cytotechnology. 2024; 76(6):749-759.
PMID: 39435413
PMC: 11490625.
DOI: 10.1007/s10616-024-00651-0.
Shankaranarayanan D, Mantri M, Lagman M, Li C, Sharma V, Muthukumar T
Hum Immunol. 2024; 85(6):111144.
PMID: 39332042
PMC: 11637971.
DOI: 10.1016/j.humimm.2024.111144.
Seefeld M, Templeton E, Lehtinen J, Sinclair N, Yadav D, Hartwell B
Front Immunol. 2024; 15:1419527.
PMID: 39286244
PMC: 11403286.
DOI: 10.3389/fimmu.2024.1419527.
Nelson A, Wang L, Laffey K, Becher L, Parks C, Hoffmann M
Front Immunol. 2024; 15:1434463.
PMID: 39281668
PMC: 11392757.
DOI: 10.3389/fimmu.2024.1434463.
Animal models for transplant immunology: bridging bench to bedside.
Kang M, Park H, Kim K, Choi D
Clin Transplant Res. 2024; 38(4):354-376.
PMID: 39233453
PMC: 11732767.
DOI: 10.4285/ctr.24.0029.
Sequential immunotherapy: towards cures for autoimmunity.
Ramirez-Valle F, Maranville J, Roy S, Plenge R
Nat Rev Drug Discov. 2024; 23(7):501-524.
PMID: 38839912
DOI: 10.1038/s41573-024-00959-8.
Expression of PD-1 and PD-L1 in Endometrial Cancer: Molecular and Clinical Significance.
Mamat Yusof M, Chew K, Kampan N, Shafiee M
Int J Mol Sci. 2023; 24(20).
PMID: 37894913
PMC: 10607163.
DOI: 10.3390/ijms242015233.
Immune-checkpoint expression in antigen-presenting cells (APCs) of cytomegaloviruses infection after transplantation: as a diagnostic biomarker.
Aghbash P, Rasizadeh R, Arefi V, Nahand J, Baghi H
Arch Microbiol. 2023; 205(8):280.
PMID: 37430000
DOI: 10.1007/s00203-023-03623-8.
The Role of Bispecific Antibodies in Relapsed Refractory Multiple Myeloma: A Systematic Review.
Khanam R, Ashruf O, Waqar S, Shah Z, Batool S, Mehreen R
Antibodies (Basel). 2023; 12(2).
PMID: 37366654
PMC: 10294881.
DOI: 10.3390/antib12020038.
Generation of a novel fully human non-superagonistic anti-CD28 antibody with efficient and safe T-cell co-stimulation properties.
Elsayed A, Pellegrino C, Pluss L, Peissert F, Benz R, Ulrich F
MAbs. 2023; 15(1):2220839.
PMID: 37288872
PMC: 10251795.
DOI: 10.1080/19420862.2023.2220839.
Abnormally primed CD8 T cells: The Achilles' heel of CHB.
Chen X, Liu X, Jiang Y, Xia N, Liu C, Luo W
Front Immunol. 2023; 14:1106700.
PMID: 36936922
PMC: 10014547.
DOI: 10.3389/fimmu.2023.1106700.
NK cells reduce anergic T cell development in early-stage tumors by promoting myeloid cell maturation.
Lindsay R, Melssen M, Stasiak K, Annis J, Woods A, Rodriguez A
Front Oncol. 2022; 12:1058894.
PMID: 36531040
PMC: 9755581.
DOI: 10.3389/fonc.2022.1058894.
Tumour Derived Extracellular Vesicles: Challenging Target to Blunt Tumour Immune Evasion.
Lopatina T, Sarcinella A, Brizzi M
Cancers (Basel). 2022; 14(16).
PMID: 36011012
PMC: 9406972.
DOI: 10.3390/cancers14164020.
Single-cell multi-omics analysis of human pancreatic islets reveals novel cellular states in type 1 diabetes.
Fasolino M, Schwartz G, Patil A, Mongia A, Golson M, Wang Y
Nat Metab. 2022; 4(2):284-299.
PMID: 35228745
PMC: 8938904.
DOI: 10.1038/s42255-022-00531-x.
Expression Dynamics of the -Glycosylated Proteins Recognized by Lectin in T Lymphocytes and Its Relationship With Moesin as an Alternative Mechanism of Cell Activation.
Gomez-Henao W, Saavedra R, Chavez-Sanchez F, Lascurain R, Zenteno E, Tenorio E
Front Immunol. 2021; 12:788880.
PMID: 34917095
PMC: 8669815.
DOI: 10.3389/fimmu.2021.788880.
Continuous Modeling of T CD4 Lymphocyte Activation and Function.
Martinez-Mendez D, Mendoza L, Villarreal C, Huerta L
Front Immunol. 2021; 12:743559.
PMID: 34804023
PMC: 8602102.
DOI: 10.3389/fimmu.2021.743559.
Upcoming treatments for morphea.
Wenzel D, Haddadi N, Afshari K, Richmond J, Rashighi M
Immun Inflamm Dis. 2021; 9(4):1101-1145.
PMID: 34272836
PMC: 8589364.
DOI: 10.1002/iid3.475.
Optimizing interleukin-2 concentration, seeding density and bead-to-cell ratio of T-cell expansion for adoptive immunotherapy.
Ghaffari S, Torabi-Rahvar M, Aghayan S, Jabbarpour Z, Moradzadeh K, Omidkhoda A
BMC Immunol. 2021; 22(1):43.
PMID: 34217218
PMC: 8254233.
DOI: 10.1186/s12865-021-00435-7.
Immunotherapy in endometrial cancer: rationale, practice and perspectives.
Cao W, Ma X, Victoria Fischer J, Sun C, Kong B, Zhang Q
Biomark Res. 2021; 9(1):49.
PMID: 34134781
PMC: 8207707.
DOI: 10.1186/s40364-021-00301-z.